Corticosteroid therapy for nephrotic syndrome

The most commonly reported side effects were: oral thrush , nausea , headache , and pain in the pharynx or larynx . More rarely reported side effects (occurring in <1% of patients during the clinical trial) include: tachycardia , palpitations , dry mouth , allergic reaction ( bronchospasm , dermatitis , hives ), pharyngitis , muscle spasms , tremor , dizziness , insomnia , nervousness , and hypertension . Patients experiencing an allergic reaction or increase in difficulty breathing while using this medication should immediately discontinue its use and contact their physician. [4]

REFERENCES:
Committee Opinion Committee on Obstetric Practice Number 210, October 1998 Antenatal Corticosteroid Therapy for Fetal Maturation
2. NIH Consensus Statement Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes1994 Feb 28-Mar 2;12(2):1-24
3. Morrison JC, Whybrew WD, Bucovaz ET, Schneider JM. Injection of corticosteroids into mother to prevent neonatal respiratory distress syndrome. Am J Obstet Gynecol 131:358,1978. MEDLINE
4. Morrison JC, Schneider JM, Whybrew WD, Bucovaz ET. Effect of corticosteroids and Fetomaternal disorders on the L:S ratio. Obstet Gynecol 56:583, 1980 MEDLINE Please review the Disclaimer before using this site. Copyright © 2000-2008 by Focus Information Technology.
All rights reserved.
Created: 11/30/2002
Update: 11/30/2002
Update: 4/15/2008

Corticosteroid therapy for nephrotic syndrome

corticosteroid therapy for nephrotic syndrome

Media:

corticosteroid therapy for nephrotic syndromecorticosteroid therapy for nephrotic syndromecorticosteroid therapy for nephrotic syndromecorticosteroid therapy for nephrotic syndromecorticosteroid therapy for nephrotic syndrome